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Short Report
Investigating smoking and nicotine
dependence among people with
severe mental illness during the
COVID-19 pandemic: analysis of linked
data from a UK Closing the Gap cohort
Emily Peckham, Victoria Allgar, Suzanne Crosland, Paul Heron, Gordon Johnston, Elizabeth Newbronner,
Elena Ratschen, Panagiotis Spanakis, Ruth Wadman, Lauren Walker and Simon Gilbody
Summary
Smoking rates are higher for people who use mental
health services, which contributes substantially to health
inequalities. Smoking can lead to worse COVID-19 outcomes,
yet it remains unclear whether smoking has changed for people
who use mental health services. We examined smoking
patterns in a large clinical cohort of people with severe mental
illness, before and during the pandemic. We found high levels of
nicotine dependence and heavier patterns of smoking. Although
some people had reported quitting, it is likely that smoking
inequalities have become further entrenched. Mental health
services should seek to mitigate this modifiable risk and source
of poor health.
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People with severe mental illness (SMI) experience profound health
inequalities, with increased rates of long-term physical health pro-
blems and behavioural risk factors, such as smoking.1 There are
concerns that the COVID-19 pandemic will disproportionately
affect the health of people with SMI, increasing already existing
health inequalities.2 Around 40% of people with SMI smoke,3 com-
pared with a current smoking prevalence in England of around
14%.4 High rates of smoking remain an important modifiable risk
factor, and there is good evidence that effective interventions can
encourage successful quitting.5
The COVID-19 pandemic has affected health risk behaviours,
and there has been an increase in quit attempts in the wider UK
population, although the impact on smoking rates remains
unclear.6 For example, in England, it has been reported that
300 000 people quit smoking7 during the first months of the pan-
demic. A national campaign urging people to ‘QuitForCOVID’
was rolled out, but it is uncertain whether people with SMI bene-
fitted from this health promotion campaign. UK population
surveys (e.g.6) have not been able to study this, and it remains pos-
sible that disparities in smoking and quitting have been further
entrenched among people with SMI during the pandemic.
Studies describing health risk behaviours among people with
SMI provide an opportunity to explore changes during the
COVID-19 pandemic. Here, we describe changes in smoking
behaviour and quitting among people with SMI.
Method
The Closing the Gap (CtG) study is a large (n = 10 176) clinical
cohort, recruited between April 2016 and March 2020.
Participants have documented diagnoses of schizophrenia or delu-
sional/psychotic illness (ICD-108 codes F20.X and F22.X or DSM IV
or Vequivalent) or bipolar disorder (ICD-10 code F31.X or DSM
equivalent). The composition of the CtG cohort has previously
been described,9 and the data at inception included descriptions
of self-reported smoking behaviour and e-cigarette use.
We aimed to explore the effects of the COVID-19 pandemic in a
subsection of this clinical cohort, and we identified participants for
the Optimising Well-being in Self-Isolation (OWLS) study (https://
sites.google.com/york.ac.uk/owls-study/home).We aimed to recruit
300 people to the OWLS study, as this number was feasible in the
timescale. To ensure that the OWLS study subcohort was represen-
tative, we created a sampling framework based on gender, age, eth-
nicity and whether they were recruited via primary or secondary
care. OWLS study participants were recruited from 17 mental
health trusts (in six clinical research networks areas across urban
and rural settings in England). People whomet the eligibility criteria
were contacted by telephone or letter, and invited to take part in the
study.
We explored smoking behaviour and e-cigarette use during the
COVID-19 pandemic. For those who reported smoking or using e-
cigarettes, we asked whether this was more, less or about the same
since the pandemic restrictions began. Those who reported
smoking also completed the Heaviness of Smoking Index (HSI),
derived from the Fagerstrom Test for Nicotine Dependence10 (i.e.
how many cigarettes per day they smoked and how long after
waking they had their first cigarette), with categories of low,
medium and high.
Changes in smoking status since completing the original CtG
survey were established by participant linkage between self-reported
smoking status before and after the pandemic restrictions began.
We also compared smoking statistics within our SMI population
with recent figures drawn from the UK-wide survey of smoking
in the general population.4
Ethics
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committees on human experimentation and with the Helsinki
Declaration of 1975, as revised in 2008. All procedures involving
human patients were approved by the North West – Liverpool
Central Research Ethics Committee (reference 20/NW/0276).
Written or verbal informed consent was obtained from all patients.
Results
Between July and December 2020, 367 people with SMI
were recruited to the OWLS study. The mean age was 50.5 (range
20–86) years, 51% were men and 77.4% were White British.
Smoking-related behaviour is given in Table 1. A total of 27.0%
(95% CI 22.6–31.7%) of study participants reported that they
smoked, compared with 14.1% of the general population,4 and
12.8% (95% CI 9.7–16.5%) of study participants reported that
they used an e-cigarette. Participants who smoked reported
smoking a mean of 17.5 cigarettes per day (minimum of 2 and
maximum of 60), compared with 9.1 of the general population.4
With reference to the HSI, 54.5% of study participants reported
smoking within 5 mins of waking, compared with 6.9% of the
general population. In terms of the HSI, 50.5% of people were mod-
erately addicted and 23.2% were highly addicted.
Of the people who reported smoking in the OWLS survey,
54.5% (95% CI 44.7–64.1%) said that they had been smoking
more heavily since the pandemic restrictions began, and 12.1%
(95% CI 6.8–19.6%) said that they had been smoking less.
A total of 355 participants provided smoking data both in the
OWLS study and in a pre-COVID-19 data collection.
Longitudinal linkage with pre-COVID-19 data showed that, by
self-report, 9.0% (95% CI 6.4–12.3%) of people with SMI had
stopped smoking. However, 5.9% (95% CI 3.8–8.7%) of people
had started smoking. This change in smoking status could have
taken place at any time between April 2016 to March 2020 (initial
data collection) and July to December 2020 (follow-up time period).
Discussion
Smoking remains one of the most important modifiable risk factors
for reduced life expectancy among people with SMI.1 To our knowl-
edge, this is the first study to examine smoking status and smoking
behaviour change for people with SMI during COVID-19, and other
smoking population surveys have not been able to study this. Our
study complements recent population surveys of mental health,11
which have either not been able to capture the experiences of
people with SMI, or have focused on mental health and not
health risk behaviours. Compared with when cohort participants
were first surveyed pre-COVID-19, the smoking rate has dropped,
which is encouraging and suggests that there have been successful
quit attempts; however, we cannot be certain whether this change
in smoking behaviour is a result of COVID-19 and the pandemic
restrictions. We also noted that smoking intensity increased for
people who currently smoke, with more than half reporting
smoking more. This suggests that although the pandemic may
have prompted some people to change their smoking behaviour,
for those who continued to smoke, aspects of the pandemic restric-
tions may have led to them smoking more.
As anticipated, when compared with the general population,4
people were smoking on average about twice as many cigarettes
per day as people without SMI, and people with SMI were nearly
ten times more likely to report smoking within 5 mins of waking.
This indicates that people with SMI who smoke are likely to have
a higher level of nicotine dependence than those without an SMI,
although we cannot link this to COVID-19. A limitation of the
study is that data on nicotine dependence were not available pre-
COVID-19. However, we propose to study temporal trends in
smoking and nicotine dependence beyond the COVID-19
pandemic.
We conclude that important disparities between the wider
population and people with SMI remain, and that smoking-
related inequalities have potentially increased since the beginning
of the COVID-19 pandemic. It is therefore important that effective
quitting services are provided for, and responsive to, the needs of
people who use mental health services.
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Table 1 Smoking behaviour, nicotine dependence and e-cigarette use
in people with severe mental illness
Characteristic
OWLS study (N = 376),
n, %
Percentage of people who smoke 99, 27.0% (95% CI 22.6–31.7%)
Mean number of cigarettes per day 17.5 (Interquartile range 10–20)
Percentage of people who smoked
within 5 mins of wakinga
54, 54.5% (95% CI 44.7–64.1%)
Heaviness of smokinga,b
Low 21, 21.2% (95% CI 14.1–30.0%)
Medium 50, 50.5% (95% CI 40.8–60.2%)
High 23, 23.2% (95% CI 15.8–32.2%)
Percentage of people who use an
e-cigarette
47, 12.8% (95% CI 9.7–16.5%)
OWLS, Optimising Well-being in Self-Isolation study.
a. Per cents are out of those who smoked.
b. Per cents do not add up to 100% because of non-responders.
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